CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The new online Learning Center with new content can still be found under the “Training” folder on ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...